Appeals court rejects Novartis’ attempt to block Entresto genericsnews2025-09-26T18:28:20+00:00September 26th, 2025|Endpoints News|
AstraZeneca offers Farxiga, Airsupra discounts on new DTC sitenews2025-09-26T17:58:25+00:00September 26th, 2025|Endpoints News|
Mission BioCapital raises $134M for sixth biotech investment fundnews2025-09-26T17:51:40+00:00September 26th, 2025|Endpoints News|
Almost 30% of industry-funded research goes unpublished, new study saysnews2025-09-26T16:35:16+00:00September 26th, 2025|Endpoints News|
Trump’s new tariff threat throws months of deals and negotiations into uncertainty news2025-09-26T16:01:06+00:00September 26th, 2025|Endpoints News|
Lilly’s Kisunla gets EU approval; Sanofi expands insulin discount programnews2025-09-26T14:52:47+00:00September 26th, 2025|Endpoints News|
Patient groups push abandoned rare disease gene therapy toward clinical trialnews2025-09-26T14:32:48+00:00September 26th, 2025|Endpoints News|
Get your CVR: Backloaded acquisitions come into focus following Metsera, 89bio dealsnews2025-09-26T13:30:47+00:00September 26th, 2025|Endpoints News|
Merck KGaA’s top-level changes continue with CEO transition; Incyte hires strategy execnews2025-09-26T11:00:12+00:00September 26th, 2025|Endpoints News|
Crinetics gets first FDA approval as Palsonify is cleared for rare hormonal disordernews2025-09-26T07:23:39+00:00September 26th, 2025|Endpoints News|
